MedPath

Validation of the german transplation of the disease-specific health-related Quality of life questionnaire (THYCA-QoL) for thyroid cancer survivors.

Recruiting
Conditions
C73
Malignant neoplasm of thyroid gland
Registration Number
DRKS00011046
Lead Sponsor
Klinik für Psychosomatik und Psychotherapie der Uniklinik Köln
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
120
Inclusion Criteria

1.) patients, that are treated in the nuclear medicine of the Uniklinik Köln
2.) the participants must have German as mother tongue or must be equipped with adequate german language skills inkl. adequate comprehension of the German language and the capability to read.
3.) min. 18 years old
4.) informed consent is written down (happens after the participants get Information over the study)

Exclusion Criteria

1.) under 18 years
2.) non-elective patients, on whom it was impossible to do a pre-stationary survey, because of organisational difficulties)

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Thyroid cancer survivors are going to be examined via cognitive interviews for the following aspects: comprehensibility of the items, how acceptable the items are, identification of misunderstandings or inconsistencies and their correction. The validation of the THYCA-QoL is ensured through the validation of the known questionnaire SF 36, PHQ-D and two QoL questionnaires (UQ QoL and QoL thyroid questionnaire). This happens at only one time point, on which the researcher goes to the nuclear medical ward and asks the patients to join the study. If the patient agrees to the conditions of the study, a individual appointment is made to do the cognitive pre-test. <br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath